Review Article: Critiques of the risk concept — valid or not?

Scandinavian Journal of Public Health

Volumn 35, Issue 6, 2007, Pages 648-654

  Nexøe, Jørgen ^a   Halvorsen, Peder Andreas ^b   Kristiansen, Ivar Sønbø ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

general practice; medical decision making; preventive healthcare; Risk

Indexed keywords

ANXIETY; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL PRACTICE; PATIENT CARE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK REDUCTION;

CONCEPT FORMATION; DECISION MAKING; FAMILY PRACTICE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; RISK; RISK FACTORS; SURVIVAL ANALYSIS; UNCERTAINTY;

EID: 36549018173     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1080/14034940701418897     Document Type: Review

References (55)

1. Brodersen J. Measuring psychosocial consequences of false-positive screening results: Breast cancer as an example. PhD thesis, Faculty of Health Sciences, University of Copenhagen, 2006.
2. Kristiansen I.S., Gyrd-Hansen D., Nexoe J., Nielsen J.B. Number needed to treat: Easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. J Clin Epidemiol 2002;55:888-892.
3. Skolbekken J.A. Communicating the risk reduction achieved by cholesterol reducing drugs. Br Med J 1998; 316:1956-8.
4. Huh J., Cude B.J. Is the information “fair and balanced” in direct-to-consumer prescription drug websites? J Health Commun 2004;9:529-540.
5. Hetlevik I. The full bucket of general practice. Tidsskr Nor Laegeforen 1999;119:3547-8 (in Norwegian).
6. Rosa E.A. The logical structure of the social amplification of risk framework (SARF): Metatheroretical foundation and policy implications. In: Pidegeon N, Kasperson RE, Slovic P, editors. The social amplification of risk. Cambridge: Cambridge University Press; 2003. p 47-79.
7. Von Neumann J., Morgenstern O. Theory of games and economic behaviour. 3rd ed. Princeton, NJ: Princeton University Press;.
8. Weinstein M.C., Fineberg H.V. Clinical decision analysis. Philadelphia: Saunders; 1980.
9. McNeil B.J., Weichselbaum R., Pauker S.G. Fallacy of the five-year survival in lung cancer. N Engl J Med 1978; 299:1397-1401.
10. Kahneman D., Tversky A. Prospect theory: An analysis of decision under risk. Econometrica 1979;47:263-292.
11. Tversky A., Kahneman D. Judgment under uncertainty — heuristics and biases. Science 1974;185:1124-1131.
12. Bell D.E. Regret in decision-making under uncertainty. Operations Res 1982;30:961-981.
13. Loomes G., Sugden R. Regret theory: An alternative theory of rational choice under uncertainty. Economic J 1982;92: 805-824.
14. Loomes G., Sugden R. Disappointment and dynamic consistency in choice under uncertainty. Rev Economic Studies 1986;53:271-282.
15. Gigerenzer G., Todd P. Simple heuristics that make us smart. Oxford: Oxford University Press; 1999.
16. Eriksson T., Nilstun T., Edwards A. The ethics of risk communication in lifestyle interventions: Consequences of patient centredness. Health, Risk & Society 2007;9:19-36.
17. Ropeik D., Slovic P. Risk communication: A neglected tool in protecting public health. Risk in Perspective 2003;11:1-4.
18. Loewenstein G.F., Weber E.U., Hsee C.K., Welch N. Risk as feelings. Psychol Bull 2001;127:267-286.
19. Goldberg J.H. Being there is important, but getting there matters too: The role of path in the valuation process. Med Decis Making 2006;26:323-337.
20. Wik L., Hansen T.B., Fylling F., Steen T., Vaagenes P., Auestad B.H., et al. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: A randomized trial. JAMA 2003; 289:1389-1395.
21. Wright J.C., Weinstein M.C. Gains in life expectancy from medical interventions: Standardizing data on outcomes. N Engl J Med 1998;339:380-6.
22. Van Hout BA, Simoons M.L. Cost-effectiveness of HMG coenzyme reductase inhibitors: Whom to treat? Eur Heart J 2001;22:751-761.
23. Nexøe J., Gyrd-Hansen D., Kragstrup J., Kristiansen I.S., Nielsen J.B. Danish GPs’ perception of disease risk and benefit of prevention. Fam Pract 2002;19:3-6.
24. Halvorsen P.A., Kristiansen I.S., Aasland O.G., Førde OH Medical doctors’ perception of the “number needed to treat” (NNT): A survey of doctors’ recommendations for two therapies with different NNT. Scand J Prim Health Care 2003;21:162-6.
25. Christensen P.M., Brøsen K., Brixen K., Andersen M., Kristiansen I.S. A randomized trial of laypersons’ perception of the benefit of osteoporosis therapy: Number needed to treat versus postponement of hip fracture. Clin Ther 2003;25:2575-2585.
26. Halvorsen P.A., Kristiansen I.S. Decisions on drug therapies by numbers needed to treat: A randomized trial. Arch Intern Med 2005;165:1140-6.
27. Nexøe J., Kristiansen I.S., Gyrd-Hansen D., Nielsen J.B. Influence of number needed to treat, costs and outcome on preferences for a preventive drug. Fam Pract 2005;22: 126-131.
28. Dahl R., Gyrd-Hansen D., Kristiansen I.S., Nexøe J., Nielsen J.B. Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey. BMC Med Inform Decis Mak 2007;7:8.
29. Cranney M., Warren E., Barton S., Gardner K., Walley T. Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract 2001;18:359-363.
30. Rose G. Sick Individuals and sick populations. Int J Epidemiol 1985;14:32-38.
31. Getz L., Sigurdsson J.A., Hetlevik I. Is opportunistic disease prevention in the consultation ethically justifiable? Br Med J 2003;327:498-500.
32. Sigurdsson J.A., Getz L., Hetlevik I. Check lists and screening: A threat against the consultation. Lakartidningen 2004;101: 1412-1415 (in Swedish).
33. Getz L., Kirkengen A.L., Hetlevik I., Romundstad S., Sigurdsson J.A. Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice: A descriptive epidemiological study. Scand J Prim Health Care 2004;22:202-8.
34. Yarnall K.S.H., Pollak K.I., Ostbye T., Krause K.M., Michener J.L. Primary care: Is there enough time for prevention? Am J Public Health 2003;93:635-641.
35. Nexøe J., Oltarzewska A.M., Sawicka-Powierza J., Kragstrup J., Kristiansen I.S. Perception of risk information: Similarities and differences between Danish and Polish general practitioners. Scand J Prim Health Care 2002;20:183-7.
36. Phillips L.S., Branch W.T., Cook C.B., Doyle J.P., El Kebbi IM, Gallina D.L., et al. Clinical inertia. Ann Intern Med 2001;135:825-834.
37. Prosser L.A., Stinnett A.A., Goldman P.A., Williams L.W., Hunink M.G., Goldman L., et al. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med 2000;132:769-779.
38. Johannesson M. The cost-effectiveness of hypertension treatment in Sweden: An analysis of the criteria for intervention and the choice of drug treatment. J Hum Hypertens 1996;10(Suppl 2):S23-S26.
39. Elstein A.S., Schwarz A. Evidence base of clinical diagnosis — clinical problem solving and diagnostic decision making: Selective review of the cognitive literature. Br Med J 2002; 324:729-732.
40. Ghosh A.K., Ghosh K. Translating evidence-based information into effective risk communication: Current challenges and opportunities. J Lab Clin Med 2005;145:171-180.
41. Sheridan S.L., Pignone M., Lewis C.L. A randomized comparison of patients’ understanding of number needed to treat and other common risk reduction formats. J Gen Intern Med 2003;18:884-892.
42. Sheridan S.L., Pignone M. Numeracy and the medical student's ability to interpret data. Eff Clin Pract 2002;5: 35-40.
43. Kristiansen I.S., Eggen A.E., Thelle D.S. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: Is individual intervention worth while? Br Med J 1991;302:1119-1122.
44. Adriaanse M.C., Snoek F.J., Dekker J.M., Spijkerman A.M., Nijpels G., Twisk J.W., et al. No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study. Diabet Med 2004; 21:992-8.
45. Braithwaite D., Emery J., Walter F., Prevost A.T., Sutton S. Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis. J Natl Cancer Inst 2004;96:122-133.
46. Christensen B., Engberg M., Lauritzen T. No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. Eur J Cardiovasc Prev Rehabil 2004;11:239-243.
47. Lupton B.S., Fonnebo V., Sogaard A.J., Fylkesnes K. The Finnmark Intervention Study: Do community-based intervention programmes threaten self-rated health and well-being? Experiences from Batsfjord, a fishing village in North Norway. Eur J Public Health 2005;15:91-96.
48. Shaw C., Abrams K., Marteau T.M. Psychological impact of predicting individuals’ risks of illness: A systematic review. Soc Sci Med 1999;49:1571-1598.
49. Almqvist E.W., Brinkman R.R., Wiggins S., Hayden M.R. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clin Genet 2003;64:300-9.
50. Hendriks K.S., Grosfeld F.J., Wilde A.A., van den B.J., van Langen I.M., van Tintelen J.P., et al. High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet 2005;8:103-113.
51. Decruyenaere M., Evers-Kiebooms G., Cloostermans T., Boogaerts A., Demyttenaere K., Dom R. et al. Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur J Hum Genet 2003;11:30-38.
52. Broadstock M., Michie S., Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000;8:731-8.
53. Butow P.N., Lobb E.A., Meiser B., Barratt A., Tucker K.M. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: A systematic review. Med J Aust 2003;178:77-81.
54. Mushlin A.I., Kern L.M., Paris M., Lambert D.R., Williams G. The value of diagnostic information to patients with chest pain suggestive of coronary artery disease. Med Decis Making 2005;25:149-157.
55. Hvas L., Reventlow S., Jensen H.L., Malterud K. Awareness of risk of osteoporosis may cause uncertainty and worry in menopausal women. Scand J Public Health 2005;33:203-7.